Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program

SIMPLE SUMMARY: Women with a BRCA1 or BRCA2 gene mutation have up to an 80% lifetime risk of breast cancer unless their breasts are surgically removed, but many decline or defer surgery and choose screening, hoping that if cancer occurs, it will be detected at a curable stage. In this study 489 wome...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Warner, Ellen, Zhu, Siqi, Plewes, Donald B., Hill, Kimberley, Ramsay, Elizabeth A., Causer, Petrina A., Seely, Jean, Jong, Roberta A., Lenkov, Pamela, Elser, Christine, Crystal, Pavel, Yaffe, Martin J., Giannakeas, Vasily, Sun, Ping, Narod, Steven A.
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7700272/
https://ncbi.nlm.nih.gov/pubmed/33238387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113479
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items